Incidence of neutrophil extracellular traps (NETs) in different membrane oxygenators: pilot in vitro experiments in commercially available coated membranes
- PMID: 39775204
- DOI: 10.1007/s10047-024-01486-4
Incidence of neutrophil extracellular traps (NETs) in different membrane oxygenators: pilot in vitro experiments in commercially available coated membranes
Abstract
Neutrophil extracellular traps (NETs) were detected in blood samples and in cellular deposits of oxygenator membranes during extracorporeal membrane oxygenation (ECMO) therapy and may be responsible for thrombogenesis. The aim was to evaluate the effect of the base material of gas fiber (GF, polymethylpentene) and heat exchange (HE) membranes and different antithrombogenic coatings on isolated granulocytes from healthy volunteers under static culture conditions. Contact of granulocytes with membranes from different ECMO oxygenators (with different surface coatings) and uncoated-GFs allowed detection of adherent cells and NETotic nuclear structures (normal, swollen, ruptured) using nuclear staining. Flow cytometry was used to identify cell activation (CD11b/CD62L, oxidative burst) of non-adherent cells. Uncoated-GFs were used as a reference. Within 3 h, granulocytes adhered to the same extent on all surfaces. In contrast, the ratio of normal to NETotic cells was significantly higher for uncoated-GFs (56-83%) compared to all coated GFs (34-72%) (p < 0.001) with no difference between the coatings. After material contact, non-adherent cells remained vital with unchanged oxidative burst function and the proportion of activated cells remained low. The expression of activation markers was independent of the origin of the GF material. In conclusion, the polymethylpentene surfaces of the GFs already induce NET formation. Antithrombogenic coatings can already reduce the proportion of NETotic nuclei. However, it cannot be ruled out that NET formation can induce thrombotic events. Therefore, new surfaces or coatings are required for future ECMO systems and long-term implantable artificial lungs.
Keywords: ECMO; Membrane oxygenators; NETosis; NETs; Neutrophil granulocytes.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Similar articles
-
Neutrophil extracellular traps - a potential trigger for the development of thrombocytopenia during extracorporeal membrane oxygenation.Front Immunol. 2024 Feb 21;15:1339235. doi: 10.3389/fimmu.2024.1339235. eCollection 2024. Front Immunol. 2024. PMID: 38449869 Free PMC article.
-
Extended Cellular Deposits on Gas Exchange Capillaries Are Not an Indicator of Clot Formation: Analysis of Different Membrane Oxygenators.ASAIO J. 2023 Apr 1;69(4):e134-e141. doi: 10.1097/MAT.0000000000001892. Epub 2023 Feb 13. ASAIO J. 2023. PMID: 36780695
-
Fibronectin coating of oxygenator membranes enhances endothelial cell attachment.Biomed Eng Online. 2013 Jan 28;12:7. doi: 10.1186/1475-925X-12-7. Biomed Eng Online. 2013. PMID: 23356939 Free PMC article.
-
Anti-thrombogenic Surface Coatings for Extracorporeal Membrane Oxygenation: A Narrative Review.ACS Biomater Sci Eng. 2021 Sep 13;7(9):4402-4419. doi: 10.1021/acsbiomaterials.1c00758. Epub 2021 Aug 26. ACS Biomater Sci Eng. 2021. PMID: 34436868 Review.
-
Evolutions of extracorporeal membrane oxygenator (ECMO): perspectives for advanced hollow fiber membrane.J Artif Organs. 2024 Mar;27(1):1-6. doi: 10.1007/s10047-023-01389-w. Epub 2023 Mar 14. J Artif Organs. 2024. PMID: 36914927 Free PMC article. Review.
References
-
- Bernhardt AM, Schrage B, Schroeder I, Trummer G, Westermann D, Reichenspurner H. Extracorporeal membrane oxygenation. Dtsch Arztebl Int. 2022;119:235–44. https://doi.org/10.3238/arztebl.m2022.0068 . (PMID: 35037618). - DOI - PubMed
-
- Lehle K, Philipp A, Foltan M, Schettler F, Ritzka M, Müller T, et al. Coagulation abnormalities in patients with COVID-19 on venovenous ECLS increased risk for technical complications and support times but had no impact on survival. Artif Organs. 2022;46:1669–81. https://doi.org/10.1111/aor.14218 . (Epub 2022/03/03 PMID: 35192198). - DOI - PubMed - PMC
-
- Lubnow M, Philipp A, Foltan M, Bull Enger T, Lunz D, Bein T, et al. Technical complications during veno-venous extracorporeal membrane oxygenation and their relevance predicting a system-exchange–retrospective analysis of 265 cases. PLoS ONE. 2014;9:e112316. https://doi.org/10.1371/journal.pone.0112316 . (Epub 2014/12/02 PMID: 25464516). - DOI - PubMed - PMC
-
- Allen S, Holena D, McCunn M, Kohl B, Sarani B. A review of the fundamental principles and evidence base in the use of extracorporeal membrane oxygenation (ECMO) in critically ill adult patients. J Intensive Care Med. 2011;26:13–26. https://doi.org/10.1177/0885066610384061 . (PMID: 21262750). - DOI - PubMed
-
- Lehle K, Philipp A, Gleich O, Holzamer A, Müller T, Bein T, et al. Efficiency in extracorporeal membrane oxygenation-cellular deposits on polymethylpentene membranes increase resistance to blood flow and reduce gas exchange capacity. ASAIO J. 2008;54:612–7. https://doi.org/10.1097/MAT.0b013e318186a807 . (PMID: 19033775). - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials